BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38113104)

  • 1. Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa.
    Lowe MM; Cohen JN; Moss MI; Clancy S; Adler JP; Yates AE; Naik HB; Yadav R; Pauli M; Taylor I; McKay A; Harris H; Kim E; Hansen SL; Rosenblum MD; Moreau JM
    JCI Insight; 2024 Feb; 9(3):. PubMed ID: 38113104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tertiary Lymphoid Structures Sustain Cutaneous B cell Activity in Hidradenitis Suppurativa.
    Lowe MM; Cohen JN; Moss MI; Clancy S; Adler J; Yates A; Naik HB; Pauli M; Taylor I; McKay A; Harris H; Kim E; Hansen SL; Rosenblum MD; Moreau JM
    bioRxiv; 2023 Feb; ():. PubMed ID: 36824918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa.
    Sabat R; Šimaitė D; Gudjonsson JE; Brembach TC; Witte K; Krause T; Kokolakis G; Bartnik E; Nikolaou C; Rill N; Coulibaly B; Levin C; Herrmann M; Salinas G; Leeuw T; Volk HD; Ghoreschi K; Wolk K
    J Allergy Clin Immunol; 2023 Apr; 151(4):1015-1026. PubMed ID: 36481267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond antibodies: B cells in Hidradenitis Suppurativa: Bystanders, contributors or therapeutic targets?
    Frew JW; Grand D; Navrazhina K; Krueger JG
    Exp Dermatol; 2020 May; 29(5):509-515. PubMed ID: 32145106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Leukocyte Populations Are Associated With Early- and Late-stage Lesions in Hidradenitis Suppurativa.
    Altman SR; Criswell SL
    J Histochem Cytochem; 2021 Mar; 69(3):191-201. PubMed ID: 33238789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microRNA effector RNA-induced silencing complex in hidradenitis suppurativa: a significant dysregulation within active inflammatory lesions.
    Hessam S; Sand M; Skrygan M; Bechara FG
    Arch Dermatol Res; 2017 Sep; 309(7):557-565. PubMed ID: 28634830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa.
    Petrasca A; Hambly R; Molloy O; Kearns S; Moran B; Smith CM; Hughes R; O'Donnell M; Zaborowski A; Winter D; Fletcher JM; Kirby B; Malara A
    PLoS One; 2023; 18(2):e0281688. PubMed ID: 36780439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4.
    Penno CA; Jäger P; Laguerre C; Hasler F; Hofmann A; Gass SK; Wettstein-Ling B; Schaefer DJ; Avrameas A; Raulf F; Wieczorek G; Lehmann JCU; Loesche C; Roth L; Röhn TA
    J Invest Dermatol; 2020 Dec; 140(12):2421-2432.e10. PubMed ID: 32387270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis.
    Gudjonsson JE; Tsoi LC; Ma F; Billi AC; van Straalen KR; Vossen ARJV; van der Zee HH; Harms PW; Wasikowski R; Yee CM; Rizvi SM; Xing X; Xing E; Plazyo O; Zeng C; Patrick MT; Lowe MM; Burney RE; Kozlow JH; Cherry-Bukowiec JR; Jiang Y; Kirma J; Weidinger S; Cushing KC; Rosenblum MD; Berthier C; MacLeod AS; Voorhees JJ; Wen F; Kahlenberg JM; Maverakis E; Modlin RL; Prens EP
    JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32853177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26.
    Scala E; Di Caprio R; Cacciapuoti S; Caiazzo G; Fusco A; Tortorella E; Fabbrocini G; Balato A
    Br J Dermatol; 2019 Nov; 181(5):1038-1045. PubMed ID: 30829398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy.
    Lowe MM; Naik HB; Clancy S; Pauli M; Smith KM; Bi Y; Dunstan R; Gudjonsson JE; Paul M; Harris H; Kim E; Shin US; Ahn R; Liao W; Hansen SL; Rosenblum MD
    JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32841223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients.
    Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
    J Dermatol Sci; 2016 Jun; 82(3):166-74. PubMed ID: 26917346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell and complement signature in severe hidradenitis suppurativa that does not respond to adalimumab.
    Hambly R; Gatault S; Smith CM; Iglesias-Martinez LF; Kearns S; Rea H; Marasigan V; Lynam-Loane K; Kirthi S; Hughes R; Fletcher JM; Kolch W; Kirby B
    Br J Dermatol; 2023 Jan; 188(1):52-63. PubMed ID: 36689500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions.
    van der Zee HH; de Ruiter L; Boer J; van den Broecke DG; den Hollander JC; Laman JD; Prens EP
    Br J Dermatol; 2012 Jan; 166(1):98-106. PubMed ID: 21929531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tertiary lymphoid structures, a historical reappraisal.
    Ribatti D
    Tissue Cell; 2024 Feb; 86():102288. PubMed ID: 38101028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What causes hidradenitis suppurativa ?-15 years after.
    Zouboulis CC; Benhadou F; Byrd AS; Chandran NS; Giamarellos-Bourboulis EJ; Fabbrocini G; Frew JW; Fujita H; González-López MA; Guillem P; Gulliver WPF; Hamzavi I; Hayran Y; Hórvath B; Hüe S; Hunger RE; Ingram JR; Jemec GBE; Ju Q; Kimball AB; Kirby JS; Konstantinou MP; Lowes MA; MacLeod AS; Martorell A; Marzano AV; Matusiak Ł; Nassif A; Nikiphorou E; Nikolakis G; Nogueira da Costa A; Okun MM; Orenstein LAV; Pascual JC; Paus R; Perin B; Prens EP; Röhn TA; Szegedi A; Szepietowski JC; Tzellos T; Wang B; van der Zee HH
    Exp Dermatol; 2020 Dec; 29(12):1154-1170. PubMed ID: 33058306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression.
    Navrazhina K; Garcet S; Zheng X; Hur HB; Frew JW; Krueger JG
    J Allergy Clin Immunol; 2022 Jan; 149(1):135-144.e12. PubMed ID: 34081946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris.
    Navrazhina K; Garcet S; Frew JW; Zheng X; Coats I; Guttman-Yassky E; Krueger JG
    J Am Acad Dermatol; 2022 Feb; 86(2):322-330. PubMed ID: 34339761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativa.
    van Straalen KR; Ma F; Tsou PS; Plazyo O; Gharaee-Kermani M; Calbet M; Xing X; Sarkar MK; Uppala R; Harms PW; Wasikowski R; Nahlawi L; Nakamura M; Eshaq M; Wang C; Dobry C; Kozlow JH; Cherry-Bukowiec J; Brodie WD; Wolk K; Uluçkan Ö; Mattichak MN; Pellegrini M; Modlin RL; Maverakis E; Sabat R; Kahlenberg JM; Billi AC; Tsoi LC; Gudjonsson JE
    J Clin Invest; 2024 Feb; 134(3):. PubMed ID: 38051587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.